LYTIR

Insider · SEC Form 4 · CEO, Counterpart Health

Conrad Wai

Filed with the SEC as Wai Conrad; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.6M of CLOV. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.6M in total.Jul: Insider sales $113KSep: Insider sales $1.4MOct: Insider sales $111KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.6M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Oct 15, 2026 23,627 shares filed Oct 19, 2026 1,042,072 shares held directly after, as filed 10b5-1 plan filing $111K
  2. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Sep 15, 2026 300,000 shares filed Sep 16, 2026 1,170,056 shares held indirectly after, as filed 10b5-1 plan filing $1.4M
  3. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Jul 15, 2026 24,215 shares filed Jul 16, 2026 1,145,699 shares held directly after, as filed 10b5-1 plan filing $113K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.